Quinn Anthony G. 4
4 · Aeglea BioTherapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Quinn Anthony G.
Director
Transactions
- Purchase
Common Stock
2022-03-16$2.34/sh+80,079$187,705→ 550,540 total
Holdings
- 266,295(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $2.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]Includes 57,450 shares of common stock held by the Anthony G. Quinn Irrevocable Trust of 2018 and 208,845 shares of common stock held by the Quinn Family Irrevocable Trust of 2021(together, the "Trusts"). The Reporting Person's spouse is trustee of the Trusts.